Kura Oncology Sets Oct. 13 Webcast on Caspian Launch, KO-7246 Data
Kura Oncology will host an Oct. 13 webcast with Caspian Therapeutics to discuss Caspian's formation and KO-7246 preclinical diabetes data.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Kura Oncology will host an Oct. 13 webcast with Caspian Therapeutics to discuss Caspian's formation and KO-7246 preclinical diabetes data.
Kura Oncology, Inc. (Nasdaq: KURA) and Caspian Therapeutics, Inc. announced they will host an investor webcast on October 13, 2026, at 4:30 p.m. ET to discuss Caspian's launch and KO-7246 preclinical data in diabetes.